THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q2 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $9,646,000 | +40.6% | 323,897 | +46.0% | 0.05% | +46.9% |
| Q1 2014 | $6,863,000 | -8.4% | 221,814 | +5.6% | 0.03% | -8.6% |
| Q4 2013 | $7,489,000 | -23.5% | 210,066 | -12.2% | 0.04% | -27.1% |
| Q3 2013 | $9,789,000 | +66.1% | 239,390 | +56.5% | 0.05% | +60.0% |
| Q2 2013 | $5,895,000 | – | 153,008 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 16,538,977 | $637,247,000 | 15.84% |
| Litespeed Management, L.L.C. | 1,516,994 | $58,450,000 | 10.69% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,584,469 | $99,580,000 | 6.38% |
| Realm Partners LLC | 166,061 | $6,398,000 | 5.30% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 10,000 | $385,300,000 | 4.86% |
| SECTORAL ASSET MANAGEMENT INC | 3,167,118 | $122,029,000 | 3.61% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,004,316 | $231,346,000 | 2.92% |
| BB BIOTECH AG | 888,244 | $34,224,000 | 2.46% |
| Portolan Capital Management | 163,617 | $6,304,000 | 1.80% |
| Trellus Management Company, LLC | 20,000 | $771,000 | 0.98% |